Protocol No.: Birch Associated Soy Allergy and Immuno-Therapy (BASALIT-Study)
Laufzeit: 01.01.2010 - 31.12.2013
imported
Kurzfassung
A multi centre randomised placebo-controlled double-blind clinical trial for the evaluation of efficacy of specific immunotherapy with an aluminium hydroxide-adsorbed recombinant hypoallergenic derivative of the major birch pollen allergen r Bet v1-FV on Bet v 1 associated soy allergy” (Birch Associated Soy Allergy and Immuno-Therapy - BASALIT)
